FABP4-positive TAMs accumulate in late-stage mammary tumours, promoting their growth through the enhancing effect FABP4 has on NF-κB expression, thereby increasing the secretion of pro-tumour IL-6 signalling. The gene discussed is FABP4; the disease is breast cancer.